- 专利标题： Modified RSV F proteins and methods of their use
-
申请号： US16009257申请日： 2018-06-15
-
公开(公告)号： US11052146B2公开(公告)日： 2021-07-06
- 发明人: Peter M. Pushko , Yingyun Wu , Michael J. Massare , Ye Liu , Gale Smith , Bin Zhou
- 申请人： Novavax, Inc.
- 申请人地址： US MD Gaithersburg
- 专利权人： Novavax, Inc.
- 当前专利权人： Novavax, Inc.
- 当前专利权人地址： US MD Gaithersburg
- 代理机构： Cooley LLP
- 主分类号： A61K39/155
- IPC分类号： A61K39/155 ; A61K39/12 ; C07K14/005 ; C12N7/00 ; A61K9/00 ; A61K39/39 ; A61K9/107 ; A61K39/00
摘要：
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
公开/授权文献
- US20190134187A1 MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE 公开/授权日：2019-05-09